NICE指南:慢性肾病:评估和管理[NG203]

2021-08-25 英国国家卫生与临床优化研究所 NICE

本指南涵盖对患有慢性肾病 (CKD) 或有患慢性肾病 (CKD) 风险的人的护理和治疗。它旨在预防或延缓进展,并降低并发症和心血管疾病的风险。它还包括管理与慢性肾病相关的贫血和高磷血症。

中文标题:

NICE指南:慢性肾病:评估和管理[NG203]

英文标题:

Chronic kidney disease: assessment and management NICE guideline [NG203]

发布日期:

2021-08-25

简要介绍:

本指南涵盖对患有慢性肾病 (CKD) 或有患慢性肾病 (CKD) 风险的人的护理和治疗。它旨在预防或延缓进展,并降低并发症和心血管疾病的风险。它还包括管理与慢性肾病相关的贫血和高磷血症。

相关资料下载:
[AttachmentFileName(sort=1, fileName=慢性肾病:评估和管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fa5a41c0021662ea, title=NICE指南:慢性肾病:评估和管理[NG203], enTitle=Chronic kidney disease: assessment and management NICE guideline [NG203], guiderFrom=NICE, authorId=0, author=, summary=本指南涵盖对患有慢性肾病 (CKD) 或有患慢性肾病 (CKD) 风险的人的护理和治疗。它旨在预防或延缓进展,并降低并发症和心血管疾病的风险。它还包括管理与慢性肾病相关的贫血和高磷血症。, cover=https://img.medsci.cn/2021829/1630246135227_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence)是NHS的组织,设在伦敦和曼彻斯特。NICE成立于1999年4月1日,目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南,设定质量标准,管理国家数据库,为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Wed Aug 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>本指南涵盖对患有慢性肾病 (CKD) 或有患慢性肾病 (CKD) 风险的人的护理和治疗。它旨在预防或延缓进展,并降低并发症和心血管疾病的风险。它还包括管理与慢性肾病相关的贫血和高磷血症。</p>, tagList=[TagDto(tagId=2551, tagName=慢性肾病)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2551, guiderKeyword=慢性肾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4239, appHits=384, showAppHits=0, pcHits=792, showPcHits=3855, likes=4, shares=29, comments=14, approvalStatus=1, publishedTime=Sun Aug 29 22:36:14 CST 2021, publishedTimeString=2021-08-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 29 22:09:03 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 09:26:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=慢性肾病:评估和管理.pdf)])
慢性肾病:评估和管理.pdf
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195024, encodeId=701d1195024cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d5557035, createdName=大熊猫~~~, createdTime=Sat Feb 19 11:11:55 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082482, encodeId=999b108248215, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082481, encodeId=358a10824812b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:33 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073522, encodeId=22b910e35228f, content=下载学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/663d2bea34a2473b8f98d8cc00479b37/2ef6cb0b5b4f4511890c33c2cefb5c8c.jpg, createdBy=baf03445349, createdName=花间结缡, createdTime=Wed Nov 24 13:44:30 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070646, encodeId=f67a10e06460f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc84090633, createdName=13b7e729m66暂无昵称, createdTime=Tue Nov 16 08:37:40 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-02-19 大熊猫~~~

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195024, encodeId=701d1195024cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d5557035, createdName=大熊猫~~~, createdTime=Sat Feb 19 11:11:55 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082482, encodeId=999b108248215, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082481, encodeId=358a10824812b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:33 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073522, encodeId=22b910e35228f, content=下载学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/663d2bea34a2473b8f98d8cc00479b37/2ef6cb0b5b4f4511890c33c2cefb5c8c.jpg, createdBy=baf03445349, createdName=花间结缡, createdTime=Wed Nov 24 13:44:30 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070646, encodeId=f67a10e06460f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc84090633, createdName=13b7e729m66暂无昵称, createdTime=Tue Nov 16 08:37:40 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-12-21 ms8000000078051361

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1195024, encodeId=701d1195024cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d5557035, createdName=大熊猫~~~, createdTime=Sat Feb 19 11:11:55 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082482, encodeId=999b108248215, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082481, encodeId=358a10824812b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:33 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073522, encodeId=22b910e35228f, content=下载学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/663d2bea34a2473b8f98d8cc00479b37/2ef6cb0b5b4f4511890c33c2cefb5c8c.jpg, createdBy=baf03445349, createdName=花间结缡, createdTime=Wed Nov 24 13:44:30 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070646, encodeId=f67a10e06460f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc84090633, createdName=13b7e729m66暂无昵称, createdTime=Tue Nov 16 08:37:40 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-12-21 ms8000000078051361

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1195024, encodeId=701d1195024cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d5557035, createdName=大熊猫~~~, createdTime=Sat Feb 19 11:11:55 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082482, encodeId=999b108248215, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082481, encodeId=358a10824812b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:33 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073522, encodeId=22b910e35228f, content=下载学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/663d2bea34a2473b8f98d8cc00479b37/2ef6cb0b5b4f4511890c33c2cefb5c8c.jpg, createdBy=baf03445349, createdName=花间结缡, createdTime=Wed Nov 24 13:44:30 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070646, encodeId=f67a10e06460f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc84090633, createdName=13b7e729m66暂无昵称, createdTime=Tue Nov 16 08:37:40 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-24 花间结缡

    下载学习。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1195024, encodeId=701d1195024cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d5557035, createdName=大熊猫~~~, createdTime=Sat Feb 19 11:11:55 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082482, encodeId=999b108248215, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:54 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082481, encodeId=358a10824812b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f35647148, createdName=ms8000000078051361, createdTime=Tue Dec 21 09:48:33 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073522, encodeId=22b910e35228f, content=下载学习。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201112/663d2bea34a2473b8f98d8cc00479b37/2ef6cb0b5b4f4511890c33c2cefb5c8c.jpg, createdBy=baf03445349, createdName=花间结缡, createdTime=Wed Nov 24 13:44:30 CST 2021, time=2021-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070646, encodeId=f67a10e06460f, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cc84090633, createdName=13b7e729m66暂无昵称, createdTime=Tue Nov 16 08:37:40 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 13b7e729m66暂无昵称

    学习学习

    0

拓展阅读

慢性肾病患者贫血诊治指南(2011)

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-02-01

2011 AFCKDI亚洲慢性肾病最佳实践建议:慢性肾病的早期检测

亚洲慢性肾病计划论坛(AFCKDI,Asian Forum for Chronic Kidney Disease Initiatives) · 2011-09-30

2012KDIGO慢性肾病血压管理临床实践指南

改善全球肾脏病预后组织(KDIGO,Kidney Disease: Improving Global Outcomes) · 2012-12-05

2012KDIGO慢性肾病评估与管理临床实践指南

改善全球肾脏病预后组织(KDIGO,Kidney Disease: Improving Global Outcomes) · 2013-01-03

2013 NICE CG157:慢性肾病 (CKD) 高磷酸盐血症管理临床指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2013-03-13

2013 KDIGO慢性肾病血脂管理临床实践指南

改善全球肾脏病预后组织(KDIGO,Kidney Disease: Improving Global Outcomes) · 2013-11-04